MyFinsight
Home
Blog
About
Short-term investments
$121,341K
(-33.18%↓ Y/Y)
Cash and cash
equivalents
$32,429K
(-21.38%↓ Y/Y)
Prepaid expenses and
other current assets
$3,480K
(-43.62%↓ Y/Y)
Accounts receivable
$703K
(-49.61%↓ Y/Y)
Total current assets
$157,953K
(-31.44%↓ Y/Y)
Property and equipment,
net
$51,546K
(-15.63%↓ Y/Y)
Operating lease
right-of-use assets
$40,554K
(-7.44%↓ Y/Y)
Restricted cash
$10,050K
(-1.73%↓ Y/Y)
Total assets
$260,103K
(-30.01%↓ Y/Y)
Total liabilities and
stockholders equity
$260,103K
(-30.01%↓ Y/Y)
Total stockholders
equity
$153,438K
(-41.29%↓ Y/Y)
Operating lease
liabilities, net of current...
$70,753K
(-6.50%↓ Y/Y)
Total current
liabilities
$32,592K
(13.67%↑ Y/Y)
Cirm award
liability, net of current...
$2,377K
(-57.55%↓ Y/Y)
Stock price
appreciation milestones
$943K
(194.69%↑ Y/Y)
Accumulated deficit
-$1,595,681K
(-8.57%↓ Y/Y)
Accumulated other
comprehensive income (loss)
-$117K
(-288.71%↓ Y/Y)
Additional paid-in capital
$1,749,116K
(1.05%↑ Y/Y)
Accrued expenses
$14,904K
(-18.03%↓ Y/Y)
Cirm award
liability, current portion
$9,508K
(1095.97%↑ Y/Y)
Operating lease
liabilities, current portion
$4,922K
(-12.98%↓ Y/Y)
Accounts payable
$3,258K
(-19.36%↓ Y/Y)
Common stock, 0.001 par
value authorized...
$117K
(1.74%↑ Y/Y)
Preferred stock, 0.001 par
value authorized...
$3K
(0.00%↑ Y/Y)
Back
Back
Balance Sheet
FATE THERAPEUTICS INC (FATE)
FATE THERAPEUTICS INC (FATE)
source: myfinsight.com